The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever
Open accessAbstract
This is the first in a series of practice guidelines commissioned by the Infectious Diseases Society of America through its Practice Guidelines Committee. The purpose of these guidelines is to provide assistance to clinicians when making decisions on treating the conditions specified in each guideline. The targeted providers are internists, pediatricians, and family practitioners. The targeted patients and setting for the fever and neutropenia guideline are hospitalized individuals with neutropenia secondary to cancer chemotherapy. Panel members represented experts in adult and pediatric infectious diseases and oncology. The guidelines are evidence-based. A standard ranking system was used for the strength of the recommendations and the quality of the evidence cited in the literature reviewed. The document has been subjected to external review by peer reviewers as well as by the Practice Guidelines Committee and was approved by the IDSA Council. An executive summary, algorithms, and tables highlight the major recommendations. The guideline will be listed on the IDSA home page at http://www.idsociety.org.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
Self-citationCrawford, J., Ozer, H., Stoller, R., Johnson, D., Lyman, G., Tabbara, I., Kris, M., Grous, J., Picozzi, V., Rausch, G., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107183250305 · Cited by 1,390
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937
Pizzo, P. A., Robichaud, K. J., Gill, F. A., & Witebsky, F. G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90594-0 · Cited by 859
Self-citationPizzo, P. A., Hathorn, J. W., Hiemenz, J., Browne, M., Commers, J., Cotton, D., Gress, J., Longo, D., Marshall, D., McKnight, J., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150905 · Cited by 585
Self-citationHughes, W. T., Armstrong, D., Bodey, G. R., Feld, R., Mandell, G. L., Meyers, J. D., Pizzo, P. A., Schimpff, S. C., Shenep, J. L., Wade, J. C., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.3.381 · Cited by 403
Self-citationHickman Catheter Infections in Patients With Malignancies
PRESS, O. W., RAMSEY, P. G., LARSON, E. B., FEFER, A., & HICKMAN, R. O. (1984) · Medicine · doi:10.1097/00005792-198407000-00001 · Cited by 400
Successful Intermittent Chemoprophylaxis for Pneumocystis carinii Pneumonitis
Hughes, W. T., Rivera, G. K., Schell, M. J., Thornton, D., & Lott, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162604 · Cited by 398
Self-citationElting, L. S., Bodey, G. P., & Keefe, B. H. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1201 · Cited by 377
Self-citationWingard, J. R., Merz, W. G., Rinaldi, M. G., Miller, C. B., Karp, J. E., & Saral, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.1847 · Cited by 340
Weinstein, M. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.40 · Cited by 324
Bacteremia due to viridans streptococci in neutropenic patients: A review
Bochud, P.-Y., Calandra, T., & Francioli, P. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90009-4 · Cited by 300
Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer
Rubenstein, E. B., Rolston, K., Escalante, C., Manzullo, E., Hughes, P., Fender, A., Elting, L., Bodey, G. P., Holmes, F., Loewy, J., et al. (1993) · Cancer · doi:10.1002/1097-0142(19930601)71:11<3640::aid-cncr2820711128>3.0.co;2-h · Cited by 286
Self-citationCometta, A., Zinner, S., de Bock, R., Calandra, T., Gaya, H., Klastersky, J., Langenaeken, J., Paesmans, M., Viscoli, C., & Glauser, M. P. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.445 · Cited by 245
Duration of empiric antibiotic therapy in granulocytopenic patients with cancer
Pizzo, P. A., Robichaud, K. J., Gill, F. A., Witebsky, F. G., Levine, A. S., Deisseroth, A. B., Glaubiger, D. L., MacLowry, J. D., Magrath, I. T., Poplack, D. G., et al. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90390-5 · Cited by 238
Self-citationTalcott, J. A., Whalen, A., Clark, J., Rieker, P. P., & Finberg, R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.107 · Cited by 230
De Pauw, B. E., Deresinski, S. C., Feld, R., Lane-Allman, E. F., & Donnelly, J. P. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-10-199405150-00004 · Cited by 228
Self-citationPurpose of Quality Standards for Infectious Diseases
Gross, P. A., Barrett, T. L., Dellinger, E. P., Krause, P. J., Martone, W. J., McGowan, J. E., Sweet, R. L., & Wenzel, R. P. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.421 · Cited by 223
Malik, I. A., Khan, W. A., Karim, M., Aziz, Z., & Ata Khan, M. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80367-2 · Cited by 221
Freifeld, A. G., Walsh, T., Marshall, D., Gress, J., Steinberg, S. M., Hathorn, J., Rubin, M., Jarosinski, P., Gill, V, & Young, R. C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.165 · Cited by 211
the EORTC International Antimicrobial Therapy Cooperative Group, Cometta, A., & Program, T. G. I. (1997) · Febrile Neutropenia · doi:10.1007/978-3-642-60443-0_16 · Cited by 196
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center
Kern, W. V., Andriof, E., Oethinger, M., Kern, P., Hacker, J., & Marre, R. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.681 · Cited by 193
Escherichia coli Resistant to Fluoroquinolones in Patients with Cancer and Neutropenia
Cometta, A., Calandra, T., Bille, J., & Glauser, M. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301717 · Cited by 190
Benezra, D., Kiehn, T. E., Gold, J. W. M., Brown, A. E., Turnbull, A. D. M., & Armstrong, D. (1988) · The American Journal of Medicine · doi:10.1016/s0002-9343(88)80084-6 · Cited by 181
Self-citationLucas, K. G., Brown, A. E., Armstrong, D., Chapman, D., & Heller, G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960215)77:4<791::aid-cncr27>3.0.co;2-v · Cited by 178
Self-citationCarratala, J., Fernandez-Sevilla, A., Tubau, F., Callis, M., & Gudiol, F. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.3.557 · Cited by 177
Shenep, J. L., Hughes, W. T., Roberson, P. K., Blankenship, K. R., Baker, D. K., Meyer, W. H., Gigliotti, F., Sixbey, J. W., Santana, V. M., Feldman, S., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191604 · Cited by 168
Self-citationWinston, D. J., Ho, W. G., Bruckner, D. A., & Champlin, R. E. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-11-849 · Cited by 161
Catheter-Related Infections Caused by the Mycobacterium fortuitum Complex: 15 Cases and Review
RAAD, I. I., Vartivarian, S. E., Khan, A. M., et al. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.6.1120 · Cited by 147
Malik, I. A., Malik, I. A., Abbas, Z., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)90674-r · Cited by 137
Mullen, C. A., & Buchanan, G. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.12.1998 · Cited by 135
Empiric antibiotic therapy for granulocytopenic cancer patients.
Sc, S. (1986) · PubMed · Cited by 133
Ofloxacin versus Vancomycin/Polymyxin for prevention of infections in granulocytopenic patients
Winston, D. J., Ho, W. G., Bruckner, D. A., Gale, R. P., & Champlin, R. E. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90125-w · Cited by 132
Schaffner, A., & Schaffner, M. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/172.4.1035 · Cited by 120
Bash, R. O., Katz, J. A., Cash, J., & Buchanan, G. R. (1994) · Cancer · Cited by 118
Ceftazidime Monotherapy for Empiric Treatment of Febrile Neutropenic Patients: A Metaanalysis
Sanders, J. W., Powe, N. R., & Moore, R. D. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.5.907 · Cited by 117
Meunier, F., Zinner, S. H., Gaya, H., et al. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.5.873 · Cited by 112
Interventional antimicrobial therapy in febrile neutropenic patients
Link, H., Maschmeyer, G., Meyer, P., Hiddemann, W., Stille, W., Helmerking, M., & D. Adam for the study group of the Paul Ehrlich Society for Chemotherapy (1994) · Annals of Hematology · doi:10.1007/bf01700277 · Cited by 107
Ellis, M. E., Clink, H. M., Ernst, P., Halim, M. A., Padmos, A., Spence, D. J., Kalin, M., Qadri, S. M. H., Burnie, J., & Greer, W. (1994) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf02026116 · Cited by 96
Vellenga, E., Groot, C. A. U.-D., de Wit, R., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.619 · Cited by 96
Evaluation of New Anti-Infective Drugs for the Treatment of Febrile Episodes in Neutropenic Patients
Hughes, W. T., Pizzo, P. A., Wade, J. C., Armstrong, D., Webb, C. D., & Young, L. S. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.supplement_1.s206 · Cited by 95
Self-citationAnaissie, E. J., Vartivarian, S. E., Bodey, G. P., Legrand, C., Kantarjian, H. M., Abi-Said, D., Karl, C. L., & Vadhan‐Raj, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90006-6 · Cited by 95
Self-citationRiikonen, P. V., Saarinen, U. M., Mäkipernaa, A., et al. (1994) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199403000-00006 · Cited by 94
Bhatia, S., McCullough, J., Perry, E. H., et al. (1994) · Transfusion · doi:10.1046/j.1537-2995.1994.34394196620.x · Cited by 94
Ramphal, R., Bolger, M., Oblon, D. J., et al. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.5.1062 · Cited by 87
Rubinstein, E., Lode, H. M., Grassi, C., & Antibiotic Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.5.1217 · Cited by 85
Home treatment of febrile neutropenia: An empirical oral antibiotic regimen
Gardembas-Pain, M., Desablens, B., Sensebé, L., et al. (1991) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057996 · Cited by 84
-Lactam-Resistant Enterobacter Bacteremia in Febrile Neutropenic Patients Receiving Monotherapy
Johnson, M. P., & Ramphal, R. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.4.981 · Cited by 80
Menichetti, F., Martino, P., Bucaneve, G., Gentile, G., D’Antonio, D., Liso, V., Ricci, P., Nosari, A., Buelli, M., & Carotenuto, M. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2041 · Cited by 77
Griffin, T. C., & Buchanan, G. R. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82536-3 · Cited by 77
Kureishi, A., Jewesson, P. J., Rubinger, M., et al. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2246 · Cited by 76
Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients?
Joshi, J. H., Schimpff, S. C., Tenney, J. H., et al. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90664-8 · Cited by 74
Charnas, R. L., LÜTHI, A. R., & Ruch, W. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199704000-00003 · Cited by 69
Rozdzinski, E., Kern, W. V., Reichle, A., Moritze, T., Schmeiser, T., Gaus, W., & Kurrle, E. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.4.585 · Cited by 69
Treatment of gram-positive septicemia in cancer patients
Pizzo, P. A., Ladisch, S., & Robichaud, K. J. (1980) · Cancer · Cited by 66
Self-citationRandomized trial of beta-lactam regimens in febrile neutropenic cancer patients
Anaissie, E. J., Fainstein, V., Bodey, G. P., et al. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90140-4 · Cited by 66
Self-citationAttal, M., Schlaifer, D., Rubie, H., Huguet, F., Charlet, J.-P., Bloom, E., Lemozy, J., Massip, P., Pris, J., & Laurent, G. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.5.865 · Cited by 61
Computed tomography of hepatic and splenic fungal abscesses in leukemic children
Bartley, D. L., Hughes, W. T., Parvey, L. S., & Parham, D. M. (1982) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198209000-00007 · Cited by 59
Self-citationAtypical mycobacterial infections of Hickman catheter exit sites
Flynn, P. M., HOOSER, B. V., & Gigliotti, F. (1988) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198807000-00014 · Cited by 58
Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients
Eggimann, P., Glauser, M. P., Aoun, M., et al. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/32.suppl_b.151 · Cited by 58
Whimbey, E. E., Wong, B., Kiehn, T. E., & Armstrong, D. (1984) · Journal of Clinical Microbiology · doi:10.1128/jcm.19.6.766-771.1984 · Cited by 56
Self-citationRiikonen, P. V. (1991) · Pediatric Infectious Disease · doi:10.1097/00006454-199112000-00008 · Cited by 56
Viscoti, C., Moroni, C., Boni, L., et al. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.3.397 · Cited by 54
Lau, R. C., Doyle, J., Freedman, M., et al. (1994) · Pediatric Hematology and Oncology · doi:10.3109/08880019409140541 · Cited by 54
Jones, G. R., Konsler, G. K., Dunaway, R. P., et al. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81358-7 · Cited by 52
Effect of Fluconazole Prophylaxis on Fever and Use of Amphotericin in Neutropenic Cancer Patients
Chandrasekar, P. H., Gatny, C. M., & Bone Marrow Transplantation Team (2009) · Chemotherapy · doi:10.1159/000239184 · Cited by 50
β-Lactam regimens for the febrile neutropenic patient
Bodey, G. P., Fainstein, V., Elting, L. S., Anaissie, E. J., Rolston, K. V. I., Khardori, N. M., Kantarjian, H. M., Plager, C., Murphy, W. K., Holmes, F. A., et al. (1990) · Cancer · Cited by 50
Self-citationKern, W. V., & Kurrle, E. (1991) · Infection · doi:10.1007/bf01645571 · Cited by 48
Johnson, P. R. E., Yin, J., & Tooth, J. A. (1992) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/30.2.203 · Cited by 46
Blumberg, E. A., & Reboli, A. C. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.462 · Cited by 45
Teicoplanin versus vancomycin in the empirical treatment of febrile neutropenic patients
CHOW, A. W. C., Jewesson, P. J., Kureishi, A., et al. (1993) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1993.tb01901.x · Cited by 44
RAAD, I. I., Whimbey, E. E., Rolston, K. V., Abi-Said, D., Hachem, R. Y., Pandya, R. G., Ghaddar, H. M., Karl, C. L., & Bodey, G. P. (1996) · Cancer · Cited by 43
Self-citationThe Value of Skin Biopsies in Febrile, Neutropenic, Immunocompromised Children
Allen, U. (1986) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1986.02140190069028 · Cited by 40
Marina, N. M., Shema, S. J., Bowman, L. C., Rodman, J., Douglass, E. C., Furman, W. L., Pappo, A. S., Santana, V. M., Hudson, M. M., Meyer, W. H., et al. (1994) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950230403 · Cited by 39
Cornelissen, J. J., Rozenberg-Arska, M., & Dekker, A. W. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.5.1300 · Cited by 39
Persistent Fever After Recovery From Granulocytopenia in Acute Leukemia
Talbot, G. H. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010131013 · Cited by 39
Bow, E. J., Loewen, R., & Vaughan, D. P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.907 · Cited by 37
Effects of the Combination of Gentamicin and Carbenicillin on the Bactericidal Activity of Serum
Klastersky, J. A., Vamecq, G., Cappel, R., et al. (1972) · The Journal of Infectious Diseases · doi:10.1093/infdis/125.2.183 · Cited by 35
Stopping Antibiotic Therapy in Neutropenic Patients
DiNubile, M. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-2-289 · Cited by 33
Ambulatory treatment with ceftriaxone in febrile neutropenic children.
Kaplinsky, C., Drucker, M. M., Goshen, J., et al. (1994) · PubMed · Cited by 33
Flynn, P. M., Shenep, J. L., Crawford, R., et al. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.964 · Cited by 30
Self-citationCony‐Makhoul, P., Brossard, G., Pellegrin, G. M. J. L., et al. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07934.x · Cited by 28
High dose intravenous ciprofloxacin in febrile neutropenic patients
Johnson, P. R. E., Yin, J. A. L., & Tooth, J. A. (1990) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/26.suppl_f.101 · Cited by 27
Dranitsaris, G., Tran, T. M., McGeer, A., et al. (1995) · PharmacoEconomics · doi:10.2165/00019053-199507010-00006 · Cited by 24
Archimbaud, E., Guyotat, D., Maupas, J., Ploton, C., Nageotte, A., Devaux, Y., Thomas, X., Fleurette, J., & Fiere, D. M. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90481-r · Cited by 23
Jl, P., Marie, J., Chiche, D. A., et al. (1993) · PubMed · Cited by 22
Post-sepsis prophylaxis in cancer patients
Hughes, W. T., & Patterson, G. (1984) · Cancer · Cited by 20
Self-citationSepkowitz, K. A., Brown, A. E., & Armstrong, D. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.4.810 · Cited by 16
Self-citationSanthosh‐Kumar, C. R., Ajarim, D. S., Harakati, M. S., et al. (1992) · Journal of Infection · doi:10.1016/0163-4453(92)93393-5 · Cited by 10
Gibson, J., Johnson, L. A., Snowdon, L., et al. (1994) · PubMed · Cited by 8
Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients
Smith, C. S., Milliken, S., Powles, R. L., et al. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07927.x · Cited by 6
Kelsey, S. M., Shaw, E. S., & Newland, A. C. (1992) · Journal of Chemotherapy · doi:10.1080/1120009x.1992.11739149 · Cited by 6
Traub, W. H., Spohr, M., & Bauer, D. (1986) · Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology · doi:10.1016/s0176-6724(86)80009-8 · Cited by 3
Cited by
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationLiposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
Walsh, T. J., Finberg, R. W., Arndt, C., Hiemenz, J., Schwartz, C., Bodensteiner, D., Pappas, P., Seibel, N., Greenberg, R. N., Dummer, S., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401004 · Cited by 1,205
Ozer, H., Armitage, J. O., Bennett, C. L., Crawford, J., Demetri, G. D., Pizzo, P. A., Schiffer, C. A., Smith, T. J., Somlo, G., Wade, J. C., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3558 · Cited by 1,044
Self-citationWalsh, T. J., Pappas, P., Winston, D. J., Lazarus, H. M., Petersen, F., Raffalli, J., Yanovich, S., Stiff, P., Greenberg, R., Donowitz, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejm200201243460403 · Cited by 979
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
Self-citation
Metadata
- Authors
- Hughes, W. T., Armstrong, D., Bodey, G. P., Brown, A. E., Edwards, J. E., Feld, R., Pizzo, P., Rolston, K. V. I., Shenep, J. L., & Young, L. S.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-09
- Volume
- 25
- Issue
- 3
- Pages
- 551-573
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108818954
- Cited by
- 672
- References
- 94
- FWCI
- 22.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.